Food News and Research

RSS

Dollar-sized medical device provides injured military skydiver with pain relief

St. Jude Medical, Inc. today announced the first patient implant of an Eon Mini, the world's smallest, longest-lasting, rechargeable neurostimulator to treat chronic pain of the trunk or limbs and pain from failed back surgery.

17 Sep 2008

New research puts FDA under pressure over BPA

The results of a new study which has linked a chemical commonly used to make plastic containers, to human diseases, is adding to an already heated debate about he safety of such products.

17 Sep 2008

Gastric bypass surgery does not always guarantee a significant weight loss

According to a new report gastric bypass surgery is not always a great success story.

17 Sep 2008

GlaxoSmithKline and XenoPort submit NDA for Solzira for restless legs syndrome

GlaxoSmithKline and XenoPort, Inc. announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).

16 Sep 2008

Mylan receives FDA approval for generic version of Risperdal

Mylan Inc today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Risperidone Tablets USP, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg.

16 Sep 2008

NAMPA statement regarding JAMA study on bisphenol A

As with any new research regarding potential health effects associated with bisphenol A (BPA), the North American Metal Packaging Alliance, Inc. (NAMPA) takes seriously the findings of this latest study published in the Journal of the American Medical Association (JAMA).

16 Sep 2008

New Bisphenol A study has limited capability to assess human health effects

The American Chemistry Council is aware of a new study on bisphenol A published today in the Journal of the American Medical Association that reports a statistical association between urinary bisphenol A concentrations and medical disorders in adults. As with any study, it is critically important to understand how the design of a study can limit interpretation of the study findings.

16 Sep 2008

FDA warns Ranbaxy Labs and issues import alert

The Food and Drug Administration (FDA) today issued two Warning Letters to Ranbaxy Laboratories Ltd., of the Republic of India, and an Import Alert for generic drugs produced by Ranbaxy's Dewas and Paonta Sahib plants in India.

16 Sep 2008

Trabectedin shows promise for ovarian cancer

Women with recurrent ovarian cancer can be helped by an experimental therapy using a drug already touted for its ability to fight other cancers, a finding that provides hope for improved treatment of this deadly disease.

15 Sep 2008

FDA grants approval to Talecris Biotherapeutics for Gamunex for neurological disorder CIDP

Talecris Biotherapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted approval for Gamunex (Immune Globulin Intravenous [Human], 10% Caprylate/Chromatography Purified) as a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP). CIDP is a debilitating neurological disorder that results in muscle weakness and fatigue, which can lead to severe impairment of motor skills.

15 Sep 2008

Woman dies after being scratched by a wild rat

As a rule leptospirosis victims experience severe headaches and flu-like symptoms but the severe form which is Weil's disease, causes jaundice and liver damage, and can be fatal - but it usually only affects 10% of leptospirosis victims.

15 Sep 2008

Keppra XR approved in the U.S. for partial onset seizures

UCB announced today that the U.S. Food and Drug Administration (FDA) has approved Keppra XR (levetiracetam extended-release tablets) for use as an add-on to other antiepileptic treatments for people with partial onset seizures who are 16 years of age and older. Keppra XR is expected to be available in U.S. pharmacies at the end of September 2008.

15 Sep 2008

FDA approves expanded uses for Gardasil for vaginal and vulvar cancer caused by HPV

The U.S. Food and Drug Administration has announced the approval of the vaccine Gardasil for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26.

14 Sep 2008

FDA approves Gamunex for chronic inflammatory demyelinating polyneuropathy

The U.S. Food and Drug Administration has announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms.

14 Sep 2008

FDA issues warning on milk-based infant formula manufactured in China

In response to reports of contaminated milk-based infant formula manufactured in China, the U.S. Food and Drug Administration (FDA) is issuing a Health Information Advisory.

14 Sep 2008

Health response launched for Haiti

WHO and its partners urgently need US$ 4.2 million to provide health care for many of the 800,000 people - including children and pregnant women - affected by successive tropical storms in Haiti.

14 Sep 2008

TV junk food marketing targeting children

University of Sydney researchers have found that advertisements for junk foodthat usecompetitions and give-aways are 18 times more common during the 20 most popular children's programs compared to popular adult programs.

10 Sep 2008

Houston Chronicle examines Baylor pediatric HIV/AIDS program in Burkina Faso

The Houston Chronicle on Saturday examined the Baylor College of Medicine's International Pediatric AIDS Initiative in Bobo-Dioulasso, Burkina Faso.

10 Sep 2008

Employment rates, economic factors could decrease access to employer-sponsored health coverage for workers younger than age 65, according to EBRI analysis with the same conditions

The percentage of U.S. residents younger than age 65 who had health coverage through their employer remained at 62.2% between 2006 and 2007, but that percentage likely will decline in 2008, according to a Employee Benefit Research Institute report, the Kansas City Star reports.

10 Sep 2008